Gabrielle Britton, PhD, obtained her doctorate in Neuroscience and Psychology from Indiana University Bloomington in 2000. Her research has focused on age-related conditions, with an emphasis on cognitive impairment and its progression to Alzheimer’s disease. She brings over 15 years of experience in clinical research, with a strong emphasis on cohort studies, developed during her tenure at INDICASAT AIP (2006–2025).

Dr. Britton is Co-founder and Board Member of Fundación Ciencia en Panamá and serves on the Board of Fundación Ciudad del Saber. She is a member of Panama’s Sistema Nacional de Investigación (SNI).

She currently serves as CEO of CEVAXIN (Centro de Vacunación e Investigación), a position she has held since 2025.